| 25.07.2023 07:00 | FARN | Grant of Options | RNS |
| 19.07.2023 10:27 | FARN | Faron Pharmaceuticals sees positive data from phase 1 BEXMAB trial | Alliance |
| 19.07.2023 07:01 | FARN | Faron to Hold BEXMAB Study Conference Call | Reach |
| 19.07.2023 07:00 | FARN | BEXMAB study update | RNS |
| 30.06.2023 16:52 | FARN | Holding(s) in Company | RNS |
| 29.06.2023 18:55 | RNEW, JSE, FARN | TRADING UPDATES: Ecofin US Renewables expects to pay reduced dividend | Alliance |
| 29.06.2023 07:00 | FARN | Announcement of Placing | RNS |
| 12.06.2023 07:00 | FARN | Exercise of options | RNS |
| 09.06.2023 14:34 | RGL, IES, GUN | TRADING UPDATES: Medica shareholders back takeover; Arecor optimistic | Alliance |
| 09.06.2023 08:00 | FARN | New biomarker data from BEXMAB study at EHA2023 | Reach |
| 05.06.2023 07:00 | FARN | Board Member to Assume Transactional Advisor Role | RNS |
| 24.04.2023 14:21 | FARN | Faron Pharmaceuticals test data shows efficacy of bexmarilimab | Alliance |
| 24.04.2023 07:00 | FARN | Bexmarilimab Efficacy and Safety in MATINS Trial | Reach |
| 19.04.2023 07:00 | FARN | Bexmarilimab KOL Event | Reach |
| 18.04.2023 07:00 | FARN | Poster Presentations at AACR 2023 | Reach |
| 17.04.2023 16:34 | SCGL, OBI, TMOR | TRADING UPDATES: Anglo Asian gold output down; Faron hails antibody | Alliance |
| 17.04.2023 07:00 | FARN | BEXMAB study update | RNS |
| 13.04.2023 16:30 | FARN | Faron at Canaccord Oncology Virtual Conference | Reach |
| 29.03.2023 10:42 | FARN | Faron Pharma names James O'Brien, once of Bristol-Myers, as new CFO | Alliance |
| 29.03.2023 07:00 | FARN | Appointment of Chief Financial Officer | RNS |
| 24.03.2023 13:35 | FARN | Board Change | RNS |
| 24.03.2023 13:30 | FARN | Results of AGM | RNS |
| 22.03.2023 07:00 | FARN | Positive FDA Feedback to Progress Bexmarilimab | RNS |
| 17.03.2023 15:42 | KITW, FARN | UK shareholder meetings calendar - next 7 days | Alliance |
| 03.03.2023 11:53 | FARN | Faron Pharmaceuticals annual loss widens on higher research costs | Alliance |
| 03.03.2023 09:00 | FARN | Notice of Faron Pharmaceuticals Ltd’s AGM | RNS |
| 03.03.2023 07:15 | FARN | Faron´s Annual Report 2022 Published | RNS |
| 03.03.2023 07:00 | FARN | Financial Statement January 1 to December 31 2022 | RNS |
| 24.02.2023 15:49 | RMV, PSON, PHI | UK earnings, trading statements calendar - next 7 days | Alliance |
| 06.02.2023 18:00 | FARN | Update to Faron’s Financial Calendar for 2023 | RNS |
| 06.02.2023 07:00 | FARN | Notice of 2022 Full-Year Results and Annual Report | Reach |
| 01.02.2023 15:45 | FARN | Holding(s) in Company | RNS |
| 27.01.2023 18:56 | FARN, TMO, MERC | TRADING UPDATES: Diaceutics wins two deals; Faron proposes placing | Alliance |
| 27.01.2023 17:45 | FARN | Holding(s) in Company | RNS |
| 27.01.2023 10:28 | FARN | IN BRIEF: Faron Pharmaceuticals raises EUR12 million via shares | Alliance |
| 27.01.2023 10:11 | SPEC, GRL, FARN | AIM WINNERS & LOSERS: Faron Pharmaceuticals raises EUR12 million | Alliance |
| 27.01.2023 07:00 | FARN | Results of Placing | RNS |
| 26.01.2023 16:30 | FARN | Proposed Issue and Placing | RNS |
| 16.01.2023 16:26 | ACPE, FARN, LBOW | TRADING UPDATES: Tungsten West 'largest Western tungsten producer' | Alliance |
| 16.01.2023 11:00 | FARN | Price Monitoring Extension | RNS |
| 16.01.2023 09:05 | FARN | Second Price Monitoring Extn | RNS |
| 16.01.2023 09:00 | FARN | Price Monitoring Extension | RNS |
| 16.01.2023 07:00 | FARN | Title: BEXMAB study update | RNS |
| 23.12.2022 07:00 | FARN | Faron’s Financial Calendar for 2023 | RNS |
| 05.12.2022 12:06 | FARN | Faron Pharmaceuticals sees patient remission in immunotherapy trials | Alliance |
| 05.12.2022 07:00 | FARN | BEXMAB Study Update | RNS |
| 01.12.2022 21:42 | ATOM, GSP, RCOI | TRADING UPDATES: Renalytix hails trial results; Kingswood buys JFP | Alliance |
| 01.12.2022 07:00 | FARN | Faron Appoints Maija Hollmén PhD as CSO | RNS |
| 18.11.2022 19:49 | PPP, FARN, UPL | TRADING UPDATES: Joules nomad resigns; Pharma C loss narrows | Alliance |
| 18.11.2022 16:30 | FARN | Amendment Terms and Conditions with IPF Partners | RNS |
| 02.11.2022 07:00 | FARN | Faron Announces Poster Presentation at SITC | Reach |
| 31.10.2022 19:58 | FARN, BLU, RQIH | TRADING UPDATES: 4Global wins deal; James Cropper profit warning | Alliance |
| 31.10.2022 07:00 | FARN | BEXMAB Study Update | RNS |
| 19.10.2022 09:20 | FARN | Holding(s) in Company | RNS |
| 18.10.2022 12:30 | FARN | Holding(s) in Company | RNS |
| 18.10.2022 07:00 | FARN | Faron Announces Melanoma Cohort Data from MATINS | Reach |
| 14.10.2022 11:14 | FARN | Faron Pharmaceuticals shares down as raises EUR8.4 million in placing | Alliance |
| 14.10.2022 07:00 | FARN | Results of Placing | RNS |
| 13.10.2022 21:17 | SDR, CTL, FARN | TRADING UPDATES: Bidstack names new COO; Fintel expands deal | Alliance |
| 13.10.2022 17:31 | FARN | Proposed Issue and Placing of Shares | RNS |
| 22.09.2022 07:00 | FARN | Grant of Options | RNS |
| 20.09.2022 07:00 | FARN | Top-Line Data on Bexmarilimab Dose Variation | RNS |
| 14.09.2022 07:00 | FARN | Faron to Host Bexmarilimab Update Webcast | Reach |
| 13.09.2022 07:00 | FARN | Traumakine Data Presented at MHSR Symposium | Reach |
| 07.09.2022 13:00 | FARN | Faron to Present at Upcoming Conferences | Reach |
| 25.08.2022 12:10 | FARN | REPEAT: Faron Pharma half-year loss widens on higher R&D spending | Alliance |
| 25.08.2022 11:43 | FARN | Faron Pharmaceuticals half-year loss widens on higher R&D spending | Alliance |
| 25.08.2022 07:00 | FARN | Faron Reports 2022 Half-Year Financial Results | RNS |
| 18.08.2022 16:02 | S32, MACF, HTG | UK earnings, trading statements calendar - next 7 days | Alliance |
| 08.08.2022 07:00 | FARN | Notice of Half-Year Financial Results | RNS |
| 07.07.2022 09:45 | FARN | Results of EGM | RNS |
| 30.06.2022 17:00 | FARN | Holding(s) in Company | RNS |
| 30.06.2022 15:59 | TOM, SVT, PU13 | UK shareholder meetings calendar - next 7 days | Alliance |
| 28.06.2022 18:03 | FARN | IN BRIEF: Faron raises EUR5 million for bexmarilimab development | Alliance |
| 28.06.2022 13:47 | FARN | Registration of New Shares | RNS |
